Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer
Ontology highlight
ABSTRACT: RATIONALE: Pyridoxine (vitamin B6) may prevent or lessen hand-foot syndrome caused by chemotherapy. It is not yet known whether pyridoxine is more effective than a placebo in preventing hand-foot syndrome.
PURPOSE: This phase III randomized trial is studying pyridoxine to see how well it works compared to a placebo in preventing hand-foot syndrome in patients who are receiving capecitabine for advanced colorectal cancer or breast cancer.
DISEASE(S): Palmar-plantar Erythrodysesthesia,Colon Cancer,Colorectal Cancer,Hand-foot Syndrome,Colorectal Neoplasms,Breast Neoplasms,Hand-foot Syndrome In Patients With Advanced Colorectal Or Breast Cancer,Breast Cancer
PROVIDER: 2046490 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA